ANWELLIN Trademark

Trademark Overview


On Friday, November 5, 2021, a trademark application was filed for ANWELLIN with the United States Patent and Trademark Office. The USPTO has given the ANWELLIN trademark a serial number of 97111093. The federal status of this trademark filing is REGISTERED as of Tuesday, September 19, 2023. This trademark is owned by SinoCellTech Ltd.. The ANWELLIN trademark is filed in the Pharmaceutical Products category with the following description:

vaccines; medicines for human purpose, namely, pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations, namely, pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietetic beverages and foods adapted for medical use; medical diagnostic reagents; blood products, namely, blood for medical purposes
anwellin

General Information


Serial Number97111093
Word MarkANWELLIN
Filing DateFriday, November 5, 2021
Status700 - REGISTERED
Status DateTuesday, September 19, 2023
Registration Number7166839
Registration DateTuesday, September 19, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 4, 2023

Trademark Statements


Goods and Servicesvaccines; medicines for human purpose, namely, pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations, namely, pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietetic beverages and foods adapted for medical use; medical diagnostic reagents; blood products, namely, blood for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSinoCellTech Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBeijing XXXXX
CN

Party NameSinoCellTech Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBeijing XXXXX
CN

Party NameSinoCellTech Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBeijing XXXXX
CN

Trademark Events


Event DateEvent Description
Tuesday, September 19, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 19, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 14, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 1, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 15, 2023ASSIGNED TO LIE
Thursday, February 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 18, 2022NON-FINAL ACTION E-MAILED
Thursday, August 18, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 16, 2022ASSIGNED TO EXAMINER
Tuesday, November 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 9, 2021NEW APPLICATION ENTERED